Laboratory of Integrative Neuroendocrinology, Department of Veterinary Biomedical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, S7V 1H2, Canada.
Laboratory of Integrative Neuroendocrinology, Department of Veterinary Biomedical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, S7V 1H2, Canada.
Mol Cell Endocrinol. 2021 Oct 1;536:111401. doi: 10.1016/j.mce.2021.111401. Epub 2021 Jul 22.
Nucleobindin (NUCB)-derived peptides, nesfatin-1 (NES-1) and nesfatin-1-like peptide (NLP) have several physiological roles in vertebrates. While NES-1 is implicated in stress, whether NUCB1/NLP and NUCB2/NES-1 have any effect on proopiomelanocortin (POMC) remains unknown. The main aim of this study was to determine if NES-1 and/or NLP affect POMC synthesis in mouse corticotrophs. Immunocytochemistry was employed to target NUCB colocalization with POMC in immortalized mouse tumoral corticotrophs (AtT-20 cells). The ability of NES-1 and NLP to modulate POMC mRNA and protein in AtT-20 cells was assessed by qPCR and Western blot, respectively. Moreover, cell-signaling molecules mediating the effect of NES-1 and NLP on POMC synthesis in mouse tumoral corticotrophs were studied using pharmacological blockers. Mouse tumoral corticotrophs showed immunoreactivity for both NUCB1/NLP and NUCB2/NES-1. Both NES-1 and NLP exerted a stimulatory effect on POMC transcript abundance and protein expression in a dose- and time-dependent manner. This effect was comparable to corticotropin-releasing factor (CRF, positive control) stimulation of POMC. Incubation of mouse tumoral corticotrophs with NES-1 or NLP upregulated the phosphorylation of protein kinase A (PKA) and cAMP-response element-binding protein (CREB). The stimulatory effect of these peptides on POMC transcript abundance and protein expression was blocked by the PKA inhibitor, H89, and an adenylate cyclase inhibitor, 2',3'-dideoxyadenosine (DDA). These pharmacological studies indicate that NES-1 and NLP act through the cAMP/PKA/CREB cellular pathway to stimulate POMC synthesis. Our results provide molecular evidence to support a stimulatory role for nucleobindin-derived peptides on POMC synthesis from corticotrophs. Collectively, this research indicates that corticotrophs produce NUCBs, and the encoded peptides NES-1 and NLP could elicit a direct action to stimulate the pituitary stress hormone. This stimulatory effect is mediated by an uncharacterized G protein-coupled receptor (GPCR) that utilizes the cAMP/PKA/CREB pathway.
核结合蛋白 (NUCB) 衍生肽, nesfatin-1 (NES-1) 和 nesfatin-1 样肽 (NLP) 在脊椎动物中具有多种生理作用。虽然 NES-1 与应激有关,但 NUCB1/NLP 和 NUCB2/NES-1 是否对 proopiomelanocortin (POMC) 有任何影响尚不清楚。本研究的主要目的是确定 NES-1 和/或 NLP 是否影响小鼠嗜铬细胞瘤中的 POMC 合成。免疫细胞化学用于靶向 NUCB 与永生性小鼠肿瘤嗜铬细胞瘤 (AtT-20 细胞) 中的 POMC 的共定位。通过 qPCR 和 Western blot 分别评估 NES-1 和 NLP 对 AtT-20 细胞中 POMC mRNA 和蛋白的调节能力。此外,使用药理学阻滞剂研究介导 NES-1 和 NLP 对小鼠肿瘤嗜铬细胞瘤中 POMC 合成影响的细胞信号分子。小鼠肿瘤嗜铬细胞瘤显示对 NUCB1/NLP 和 NUCB2/NES-1 均有免疫反应性。NES-1 和 NLP 均以剂量和时间依赖的方式对 POMC 转录物丰度和蛋白表达产生刺激作用。这种作用与促肾上腺皮质释放因子 (CRF,阳性对照) 刺激 POMC 的作用相当。孵育小鼠肿瘤嗜铬细胞瘤用 NES-1 或 NLP 上调蛋白激酶 A (PKA) 和 cAMP 反应元件结合蛋白 (CREB) 的磷酸化。这些肽对 POMC 转录物丰度和蛋白表达的刺激作用被 PKA 抑制剂 H89 和腺苷酸环化酶抑制剂 2',3'-二脱氧腺苷 (DDA) 阻断。这些药理学研究表明,NES-1 和 NLP 通过 cAMP/PKA/CREB 细胞途径发挥作用,刺激 POMC 合成。我们的结果提供了分子证据,支持核结合蛋白衍生肽对来自嗜铬细胞瘤的 POMC 合成的刺激作用。总的来说,这项研究表明,嗜铬细胞瘤产生 NUCBs,编码的肽 NES-1 和 NLP 可以直接作用刺激垂体应激激素。这种刺激作用是由一种未被表征的 G 蛋白偶联受体 (GPCR) 介导的,该受体利用 cAMP/PKA/CREB 途径。